Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Source :: PR Newswire. August 29, 2024
Publication Year :: 2024
Abstract: HOLON, Israel, Aug. 29, 2024 /PRNewswire/ -- http://www.cgen.com/(Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will present virtually [...]

Subjects :: AstraZeneca PLC -- Licensing agreements
Compugen Ltd. -- Licensing agreements
Biotechnology industry -- Licensing agreements
Viral antibodies
Conferences and conventions
Antibodies
Pharmaceutical industry -- Licensing agreements
Company licensing agreement
Business
News, opinion and commentary

Tools